When.com Web Search

  1. Ads

    related to: treatment for lupus arthritis

Search results

  1. Results From The WOW.Com Content Network
  2. Common Causes of Arthritis for Women (& How to Treat It) - AOL

    www.aol.com/common-causes-arthritis-women-treat...

    Lupus arthritis. Juvenile idiopathic arthritis. Gout. ... Which types of arthritis treatment are recommended to you can depend on the kind of arthritis that you have and how severe it is.

  3. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Belimumab is primarily used in people with systemic lupus erythematosus. When it was introduced in 2011, it was the first new drug approved to treat lupus in 56 years. [8] Sales rose to $31.2 million in the first quarter of 2012. [37] The total cost for the first year of treatment with belimumab is $28,000. [38]

  4. Lupus - Wikipedia

    en.wikipedia.org/wiki/Lupus

    Unlike rheumatoid arthritis, lupus arthritis is less disabling and usually does not cause severe destruction of the joints. Fewer than ten percent of people with lupus arthritis will develop deformities of the hands and feet. [20] People with SLE are at particular risk of developing osteoarticular tuberculosis. [21]

  5. Lupus erythematosus - Wikipedia

    en.wikipedia.org/wiki/Lupus_erythematosus

    Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints , skin , kidneys , blood cells , heart , and lungs .

  6. Azathioprine - Wikipedia

    en.wikipedia.org/wiki/Azathioprine

    Azathioprine, sold under the brand name Imuran, among others, is an immunosuppressive medication. [5] It is used for the treatment of rheumatoid arthritis, granulomatosis with polyangiitis, Crohn's disease, ulcerative colitis, and systemic lupus erythematosus; and in kidney transplants to prevent rejection.

  7. Telitacicept - Wikipedia

    en.wikipedia.org/wiki/Telitacicept

    Telitacicept (trade name Tai'ai) is a pharmaceutical drug used for the treatment of systemic lupus erythematosus (SLE). [1] It is being developed by Yantai Rongchang Pharmaceuticals and RemeGen for various autoimmune diseases. [2] In 2021, telitacicept was approved in China for the treatment of patients with active SLE. [3]

  1. Ads

    related to: treatment for lupus arthritis